FOXA1 is thought to be a positive regulator of TOX3 expression, mediated by binding to an upstream enhancer [11], and knockdown of FOXA1 in a breast cancer cell line decreased TOX3 expression [40]. Here, FOXA1 is linked to breast carcinoma.